Brandon Capital is a life sciences venture capital firm that focuses on investing in high-potential biomedical innovations, including therapeutics, medical devices, and healthtech companies. Their strategy involves a hands-on, long-term approach, providing capital, strategic guidance, and corporate infrastructure to support companies from early-stage development through to commercialization, often leveraging their Brandon BioCatalyst platform.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (50% of deals).
Portfolio
2
Fund Size
$1.3B
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Pheon Therapeutics | Series B | $120M | May 2024 |
| Pheon Therapeutics | Series A | $68M | Sep 2022 |
Top Co-Investors
Atlas Venture2 shared
Forbion2 shared
Lightspeed Venture Partners1 shared
BVF Partners LP1 shared
Perceptive Advisors1 shared
Last updated: 28 April 2026